Computational development of E3 ubiquitin ligase binding moieties in PROTACs
Proteolysis targeting chimaeras (PROTACs) are rapidly emerging small molecule drugs that exploit the cellular ubiquitin-proteasome pathway to degrade specific proteins of interest (POIs). Notably, PROTAC molecules consist of two separate moieties conjoined with a linker - one moiety binds to the POI...
Main Author: | Lam, Hilbert Yuen In |
---|---|
Other Authors: | Mu Yuguang |
Format: | Final Year Project (FYP) |
Language: | English |
Published: |
Nanyang Technological University
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/180987 |
Similar Items
-
Contribution of high-content imaging technologies to the development of anti-infective drugs
by: Ang, Michelle Lay Teng, et al.
Published: (2017) -
The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms
by: Kovács, Tibor, et al.
Published: (2017) -
Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease
by: Bose, Tanima, et al.
Published: (2017) -
Characterizing the conformational landscape of MDM2-binding p53 peptides using molecular dynamics simulations
by: Yadahalli, Shilpa, et al.
Published: (2018) -
Role of the ubiquitin-proteasome pathway in the inner ear : identification of an E3 ubiquitin ligase for Atoh1
by: Cheng, Yen-Fu
Published: (2015)